Tubridy Karen L 4
4 · Akebia Therapeutics, Inc. · Filed Mar 5, 2019
Insider Transaction Report
Form 4
Tubridy Karen L
SVP, Chief Development Officer
Transactions
- Award
Employee Stock Option (Right to buy)
2019-02-28+45,000→ 45,000 totalExercise: $7.28Exp: 2029-02-28→ Common Stock (45,000 underlying) - Award
Common Stock
2019-02-28+30,000→ 61,399 total
Footnotes (3)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date.
- [F2]Includes 1,170 shares of the Issuer's common stock purchased under the Issuer's 2014 Employee Stock Purchase Plan on December 31, 2018.
- [F3]The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.